Akoya Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Akoya Biosciences generated cash of -$50,899,000, which is more than the previous year. Cash used in financing activities reached the amount of $56,844,000 last year. Net change in cash is therefore $9,292,000.
Cash Flow
| 2019 | -13.77M | -12.89M | 28.56M |
|---|---|---|---|
| 2020 | -6.84M | 6.72M | 5.48M |
| 2021 | -36.06M | -5.09M | 137.03M |
| 2022 | -53.49M | -14.07M | 28.72M |
| 2023 | -50.89M | 3.34M | 56.84M |
AKYA Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 74.53M | 113.38M | 17.50M | 12.13M | 10.24M |
Operating activities | |||||
Net income | -63.32M | -70.64M | -42.93M | -16.70M | -14.75M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 8.89M | 7.14M | 4.79M | 3.81M | 3.05M |
Stock-based compensation expense | 10.43M | 7.43M | 4.03M | 477K | 153K |
| Deferred income tax benefit | 10.43M | 7.43M | 4.03M | 477K | 153K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | -7.26M | -285K | -2.97M | 6.69M | -3.37M |
Inventories | -6.33M | -5.37M | -4.62M | -684K | -4.00M |
Accounts payable | 1.14M | 1.19M | 4.36M | -3.04M | -49K |
Cash generated by operating activities | -50.89M | -53.49M | -36.06M | -6.84M | -13.77M |
Investing activities | |||||
Purchases Of Investments | 0 | -40.77M | 0 | -145K | -10M |
Investments In Property Plant And Equipment | -3.65M | -7.36M | -5.09M | -3.29M | -2.86M |
Acquisitions Net | 0 | 55K | 0 | 145K | 0 |
Cash generated by investing activities | 3.34M | -14.07M | -5.09M | 6.72M | -12.89M |
Financing activities | |||||
Common Stock Issued | 47.96M | 447K | 138.94M | 122K | 24.82M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 10.57M | 30.62M | -322K | -25.19M | 4.95M |
Cash used in financing activities | 56.84M | 28.72M | 137.03M | 5.48M | 28.56M |
Net Change In Cash | 9.29M | -38.84M | 95.87M | 5.37M | 1.89M |
Cash at end of period | 83.82M | 74.53M | 113.38M | 17.50M | 12.13M |
| Data source | Data source | Data source |